Blood Reviews
Volume 20, Issue 3 , Pages 139-159 , May 2006

Transfusion-related acute lung injury

  • Christopher C. Silliman

      Affiliations

    • Bonfils Blood Center, University of Colorado School of Medicine, 717 Yosemite Circle, Denver, CO 80230, United States
    • Departments of Pediatrics, University of Colorado School of Medicine, Denver, CO, United States
    • Surgery, University of Colorado School of Medicine, Denver, CO, United States
    • Corresponding Author InformationCorresponding author. Tel.: +303 363 2246; fax: +303 340 2616.
    • ,
  • Nathan J.D. McLaughlin

      Affiliations

    • Departments of Pediatrics, University of Colorado School of Medicine, Denver, CO, United States
    • Tel.: +303 363 5803; fax: +303 340 2616

References 

  1. Barnard RD. Indiscriminate transfusion: a critique of case reports illustrating hypersensitivity reactions. N Y State J Med. 1951;51(20):2399–2402
  2. Brittingham TE, Chaplin H. Febrile transfusion reactions caused by sensitivity to donor leukocytes and platelets. J Am Med Assoc. 1957;165(7):819–825
  3. Philipps E, Fleischner FG. Pulomonary edema in the course of a blood transfusion without overloading the circulation. Dis Chest. 1966;50(6):619–623
  4. Ward HN. Pulmonary infiltrates associated with leukoagglutinin transfusion reactions. Ann Intern Med. 1970;73(5):689–694
  5. Thompson JS, Severson CD, Parmely MJ, Marmorstein BL, Simmons A. Pulmonary hypersensitivity reactions induced by transfusion of non-HL- A leukoagglutinins. N Engl J Med. 1971;284(20):1120–1125
  6. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion. 1985;25(6):573–577
  7. Holness L, Knippen MA, Simmons L, Lachenbruch PA. Fatalities caused by TRALI. Transfus Med Rev. 2004;18(3):184–188
  8. Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM, et al. Transfusion-related acute lung injury: definition and review. Crit Care Med. 2005;33(4):721–726
  9. Fisk J, Snyder E, Blajchman MA. Transfusion-related acute lung injury. The Hematologist: ASH News and Reports 1[3], 4. 2004. Washington, DC, American Society of Hematology.
  10. Goldman M, Webert KE, Arnold DM, Freedman J, Hannon J, Blajchman MA. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev. 2005;19(1):2–31
  11. Kleinman S, Caulfield T, Chan P, Davenport R, McFarland J, McPhedran S, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion. 2004;44(12):1774–1789
  12. Dry SM, Bechard KM, Milford EL, Churchill WH, Benjamin RJ. The pathology of transfusion-related acute lung injury. Am J Clin Pathol. 1999;112(2):216–221
  13. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J Crit Care. 1994;9(1):72–81
  14. Lawless N, Tobias S, Mayorga MA. FiO2 and positive end-expiratory pressure as compensation for altitude-induced hypoxemia in an acute respiratory distress syndrome model: implications for air transportation of critically ill patients. Crit Care Med. 2001;29(11):2149–2155
  15. Sheppard R, Moore EE, Ryder J, Harken AH, Rezende-Neto JB, Banerjee A, et al. Primed human neutrophils on a standard peripheral blood smear. J Am Coll Surg. 2002;195(5):731
  16. Popovsky MA. Transfusion related acute lung injury. In:  Popovsky MA editors. Transfusion Reactions. 2nd ed.. Bethesda, MD: AABB Press; 2001;
  17. Kopko PM. Review: transfusion-related acute lung injury: pathophysiology, laboratory investigation, and donor management. Immunohematol. 2004;20(2):103–111
  18. Silliman CC, Paterson AJ, Dickey WO, Stroneck DF, Popovsky MA, Caldwell SA, et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion. 1997;37(7):719–726
  19. Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey WO, Podlosky L, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood. 2003;101(2):454–462
  20. Technical Manual. 14 ed. Bethesda: American Association of Blood Banks; 2002.
  21. Wallis JP. Transfusion-related acute lung injury (TRALI)–under-diagnosed and under-reported. Br J Anaesth. 2003;90(5):573–576
  22. Covin RB, Ambruso DR, England KM, Kelher M, Mehdizadehkashi Z, Boshkov LK, Masuno T, Moore EE, Kim FJ, Silliman CC. Hypotension and acute pulmonary insufficiency following transfusion of autologous red blood cells during surgery: a case report and review of the literature. Transfus Med. In press 2004.
  23. Nakagawa M, Toy P. Acute and transient decrease in neutrophil count in transfusion-related acute lung injury: cases at one hospital. Transfusion. 2004;44(12):1689–1694
  24. Wallis JP, Lubenko A, Wells AW, Chapman CE. Single hospital experience of TRALI. Transfusion. 2003;43(8):1053–1059
  25. Kopko PM, Popovsky MA, MacKenzie MR, Paglieroni TG, Muto KN, Holland PV. HLA class II antibodies in transfusion-related acute lung injury. Transfusion. 2001;41(10):1244–1248
  26. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA. 2002;287(15):1968–1971
  27. Kopko PM, Holland PV. Transfusion-related acute lung injury. Br J Haematol. 1999;105(2):322–329
  28. Silliman CC. Transfusion-related acute lung injury. Transfus Med Rev. 1999;13(3):177–186
  29. Nouraei SM, Wallis JP, Bolton D, Hasan A. Management of transfusion-related acute lung injury with extracorporeal cardiopulmonary support in a four-year-old child. Br J Anaesth. 2003;91(2):292–294
  30. Fowler AA, Hamman RF, Good JT, Benson KN, Baird M, Eberle DJ, et al. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med. 1983;98(5 Pt 1):593–597
  31. Kao GS, Wood IG, Dorfman DM, Milford EL, Benjamin RJ. Investigations into the role of anti-HLA class II antibodies in TRALI. Transfusion. 2003;43(2):185–191
  32. Kollef MH, Schuster DP. The acute respiratory distress syndrome. N Engl J Med. 1995;332(1):27–37
  33. Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ. Clinical predictors of the adult respiratory distress syndrome. Am J Surg. 1982;144(1):124–130
  34. Silliman CC, Voelkel NF, Allard JD, Elzi DJ, Tuder RM, Johnson JL, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest. 1998;101(7):1458–1467
  35. Popovsky MA. Transfusion-related acute lung injury. In:  Popovsky MA editors. Transfusion Reactions. first ed.. Bethesda, MD: American Association of Blood Banks Press; 1996;p. 167–183
  36. Popovsky MA. Breathlessness and blood: a combustible combination. Vox Sang. 2002;83(Suppl 1):147–150
  37. Vamvakas EC. Allergic and anaphylactic reactions. In:  Popovsky MA editors. Transfusion Reactions. first ed.. Bethesda, MD: American Assocaition of Blood Banks; 1996;p. 81–124
  38. Hillyer CD, Josephson CD, Blajchman MA, Vostal JG, Epstein JS, Goodman JL. Bacterial Contamination of Blood Components: Risks, Strategies, and Regulation: Joint ASH and AABB Educational Session in Transfusion Medicine. Hematology (Am Soc Hematol Educ Program). 2003;575–589
  39. Robillard P, Nawej KI, Chapdelaine A, Poole J, Garneau N. Adverse transfusion reactions with respiratory signs and symptoms including TRALI in the Quebec Hemovigilance system:2000-2003. Transfusion. 2004;44(9S):23A
  40. Renaudier PC, Vo Mai MP, Azanowsky JM, Breton P, Cheze S, Girard A, et al. Epidemiology of transfusion related acute lung injury in Gifit, the Frech Hemovigilance Database. a study of the French Hemovigilance Network. Transfusion. 2004;44(9S):23A
  41. Andreu G, Morel P, Forestier F, Debeir J, Rebibo D, Janvier G, et al. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998. Transfusion. 2002;42(10):1356–1364
  42. Stainsby D. Estimate of transfusion-related acute lung injury incidence is not supported by UK data. Vox Sang. 2003;85(2):124
  43. Van Buren NL, Stroncek DF, Clay ME, McCullough J, Dalmasso AP. Transfusion-related acute lung injury caused by an NB2 granulocyte- specific antibody in a patient with thrombotic thrombocytopenic purpura. Transfusion. 1990;30(1):42–45
  44. Rabinovici R, Bugelski PJ, Esser KM, Hillegass LM, Vernick J, Feuerstein G. ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. J Appl Physiol. 1993;74(4):1791–1802
  45. Salzer WL, McCall CE. Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury. J Clin Invest. 1990;85(4):1135–1143
  46. Roffey P, Thangathurai D, Mikhail M, Riad M, Mogos M. TRALI and massive transfusion. Resuscitation. 2003;58(1):121
  47. Medeiros BC, Kogel KE, Kane MA. Transfusion-related acute lung injury (TRALI) following platelet transfusion in a patient receiving high-dose interleukin-2 for treatment of metastatic renal cell carcinoma. Transfus Apheresis Sci. 2003;29(1):25–27
  48. Cooling L. Transfusion-related acute lung injury. JAMA. 2002;288(3):315–316
  49. Askari S, Nollet K, Debol SM, Brunstein CG, Eastlund T. Transfusion-related acute lung injury during plasma exchange: Suspecting the unsuspected. J Clin Apheresis. 2002;17(2):93–96
  50. Bray RA, Harris SB, Josephson CD, Hillyer CD, Gebel HM. Unappreciated risk factors for transplant patients: HLA antibodies in blood components. Hum Immunol. 2004;65(3):240–244
  51. Davoren A, Curtis BR, Shulman IA, Mohrbacher AF, Bux J, Kwiatkowska BJ, et al. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion. 2003;43(5):641–645
  52. Dykes A, Smallwood D, Kotsimbos T, Street A. Transfusion-related acute lung injury (Trali) in a patient with a single lung transplant. Br J Haematol. 2000;109(3):674–676
  53. Ganguly S, Carrum G, Nizzi F, Heslop HE, Popat U. Transfusion-related acute lung injury (TRALI) following allogeneic stem cell transplant for acute myeloid leukemia. Am J Hematol. 2004;75(1):48–51
  54. Leach M, Vora AJ, Jones DA, Lucas G. Transfusion-related acute lung injury (TRALI) following autologous stem cell transplant for relapsed acute myeloid leukaemia: a case report and review of the literature. Transfus Med. 1998;8(4):333–337
  55. Li GS, Ye QF, Xia SS, Chen ZS, Zeng FJ, Lin ZB, et al. Acute respiratory distress syndrome after liver transplantation: etiology, prevention and management. Hepatobiliary Pancreat Dis Int. 2002;1(3):330–334
  56. Urahama N, Tanosaki R, Masahiro K, Iijima K, Chizuka A, Kim SW, et al. TRALI after the infusion of marrow cells in a patient with acute lymphoblastic leukemia. Transfusion. 2003;43(11):1553–1557
  57. Yost CS, Matthay MA, Gropper MA. Etiology of acute pulmonary edema during liver transplantation : a series of cases with analysis of the edema fluid. Chest. 2001;119(1):219–223
  58. Bux J, Hoch J, Bindl L, Muller A, Mueller-Eckhardt C. [Transfusion associated acute pulmonary insufficiency. Diagnostic confirmation by the demonstration of granulocytic antibodies. Dtsch Med Wochenschr. 1994;119(1–2):19–24
  59. Fung YL, Goodison KA, Wong JK, Minchinton RM. Investigating transfusion-related acute lung injury (TRALI). Intern Med J. 2003;33(7):286–290
  60. Keifer JC, Kingsley CP, Roth MT, Abt AB, Romano PJ. Transfusion-related acute lung injury (TRALI) complicating colectomy for ulcerative colitis. Anesthesiology. 1998;89(4):1020–1023
  61. Madyastha PR, Jeter EK, Key LL. Cytophilic immunoglobulin G binding on neutrophils from a child with malignant osteopetrosis who developed fatal acute respiratory distress mimicking transfusion-related acute lung injury. Am J Hematol. 1996;53(3):196–200
  62. Nicolle AL, Chapman CE, Carter V, Wallis JP. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation. Transfus Med. 2004;14(3):225–230
  63. Sanchez R, Toy P. Transfusion related acute lung injury: a pediatric perspective. Pediatr Blood Cancer. 2005;45(3):248–255
  64. Yang X, Ahmed S, Chandrasekaran V. Transfusion-related acute lung injury resulting from designated blood transfusion between mother and child: a report of two cases. Am J Clin Pathol. 2004;121(4):590–592
  65. Boshkov LK, Maloney J, Bieber S, Silliman CC. Two cases of TRALI from the same platelet unit: implications for pathophysiology and the role of PMNs and VEGF. Blood. 2000;96(11):655a
  66. Bastit D, Cavelier B, Ropartz C. [White lung during granulocyte transfusion. Possible role of leukoagglutinins]. Nouv Presse Med. 1982;11(28):2156–2157
  67. Karp DD, Ervin TJ, Tuttle S, Gorgone BC, Lavin P, Yunis EJ. Pulmonary complications during granulocyte transfusions: incidence and clinical features. Vox Sang. 1982;42(2):57–61
  68. O’Connor JC, Strauss RG, Goeken NE, Knox LB. A near-fatal reaction during granulocyte transfusion of a neonate. Transfusion. 1988;28(2):173–176
  69. Rizk A, Gorson KC, Kenney L, Weinstein R. Transfusion-related acute lung injury after the infusion of IVIG. Transfusion. 2001;41(2):264–268
  70. Boxer LA, Yokoyama M, Lalezari P. Isoimmune neonatal neutropenia. J Pediatr. 1972;80(5):783–787
  71. Cartron J, Tchernia G, Celton JL, Damay M, Cheron G, Farrokhi P, et al. Alloimmune neonatal neutropenia. Am J Pediatr Hematol Oncol. 1991;13(1):21–25
  72. Kameoka J, Funato T, Miura T, Harigae H, Saito J, Yokoyama H, et al. Autoimmune neutropenia in pregnant women causing neonatal neutropenia. Br J Haematol. 2001;114(1):198–200
  73. Lalezari P. Autoimmune neutropenia. Vox Sang. 1984;46(6):418–420
  74. Minchinton RM, McGrath KM. Alloimmune neonatal neutropenia–a neglected diagnosis?. Med J Aust. 1987;147(3):139–141
  75. Niebanck AE, Kwiatkowski JL, Raffini LJ. Neutropenia following IVIG therapy in pediatric patients with immune-mediated thrombocytopenia. J Pediatr Hematol Oncol. 2005;27(3):145–147
  76. Wallis JP, Haynes S, Stark G, Green FA, Lucas GF, Chapman CE. Transfusion-related alloimmune neutropenia: an undescribed complication of blood transfusion. Lancet. 2002;360(9339):1073–1074
  77. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood. 2003;101(10):3765–3777
  78. Aird WC. Endothelial cell heterogeneity. Crit Care Med. 2003;31(4 Suppl):S221–S230
  79. Aird WC. Endothelium as an organ system. Crit Care Med. 2004;32(5 Suppl):S271–S279
  80. Lee WL, Downey GP. Neutrophil activation and acute lung injury. Curr Opin Crit Care. 2001;7(1):1–7
  81. Lien DC, Wagner WW, Capen RL, Haslett C, Hanson WL, Hofmeister SE, et al. Physiological neutrophil sequestration in the lung: visual evidence for localization in capillaries. J Appl Physiol. 1987;62(3):1236–1243
  82. Downey GP, Worthen GS, Henson PM, Hyde DM. Neutrophil sequestration and migration in localized pulmonary inflammation. Capillary localization and migration across the interalveolar septum. Am Rev Respir Dis. 1993;147(1):168–176
  83. Worthen GS, Schwab B, Elson EL, Downey GP. Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries. Science. 1989;245(4914):183–186
  84. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J. 1994;8(8):504–512
  85. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994;84(7):2068–2101
  86. Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol. 1994;55(5):662–675
  87. Jaeschke H, Smith CW. Cell adhesion and migration. III. Leukocyte adhesion and transmigration in the liver vasculature. Am J Physiol. 1997;273(6 Pt 1):G1169–G1173
  88. Aoki T, Suzuki Y, Nishio K, Suzuki K, Miyata A, Mori M, et al. Behavior of stimulated leukocytes in the pulmonary microcirculation of perfused rat lungs. Adv Exp Med Biol. 1997;428:355–362
  89. Doerschuk CM. Mechanisms of leukocyte sequestration in inflamed lungs. Microcirculation. 2001;8(2):71–88
  90. Ridger VC, Wagner BE, Wallace WA, Hellewell PG. Differential effects of CD18, CD29, and CD49 integrin subunit inhibition on neutrophil migration in pulmonary inflammation. J Immunol. 2001;166(5):3484–3490
  91. Yonekawa K, Harlan JM. Targeting leukocyte integrins in human diseases. J Leukoc Biol. 2005;77(2):129–140
  92. Ley K. Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc Res. 1996;32(4):733–742
  93. Ley K, Zakrzewicz A, Hanski C, Stoolman LM, Kansas GS. Sialylated O-glycans and L-selectin sequentially mediate myeloid cell rolling in vivo. Blood. 1995;85(12):3727–3735
  94. Lorant DE, McEver RP, McIntyre TM, Moore KL, Prescott SM, Zimmerman GA. Activation of polymorphonuclear leukocytes reduces their adhesion to P-selectin and causes redistribution of ligands for P-selectin on their surfaces. J Clin Invest. 1995;96(1):171–182
  95. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung Injury (TRALI). Blood. 2004;
  96. Thommasen HV, Russell JA, Boyko WJ, Hogg JC. Transient leucopenia associated with adult respiratory distress syndrome. Lancet. 1984;1(8381):809–812
  97. Drost EM, MacNee W. Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis. Eur J Immunol. 2002;32(2):393–403
  98. Reutershan J, Ley K. Bench-to-bedside review: acute respiratory distress syndrome - how neutrophils migrate into the lung. Crit Care. 2004;8(6):453–461
  99. Tanaka H, Nishino M, Dahms TE. Physiologic responses to small emboli and hemodynamic effects of changes in deformability of polymorphonuclear leukocytes in isolated rabbit lung. Microvasc Res. 2002;63(1):81–90
  100. Grundy JE, Lawson KM, MacCormac LP, Fletcher JM, Yong KL. Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration. J Infect Dis. 1998;177(6):1465–1474
  101. Wyman TH, Bjornsen AJ, Elzi DJ, Smith CW, England KM, Kelher M, et al. A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release. Am J Physiol Cell Physiol. 2002;283(6):C1592–C1603
  102. Jagels MA, Daffern PJ, Hugli TE. C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion. Immunopharmacology. 2000;46(3):209–222
  103. Motosugi H, Graham L, Noblitt TW, Doyle NA, Quinlan WM, Li Y, et al. Changes in neutrophil actin and shape during sequestration induced by complement fragments in rabbits. Am J Pathol. 1996;149(3):963–973
  104. Ward PA. Role of complement, chemokines, and regulatory cytokines in acute lung injury. Ann N Y Acad Sci. 1996;796:104–112
  105. Lien DC, Henson PM, Capen RL, Henson JE, Hanson WL, Wagner WW, et al. Neutrophil kinetics in the pulmonary microcirculation during acute inflammation. Lab Invest. 1991;65(2):145–159
  106. Burns JA, Issekutz TB, Yagita H, Issekutz AC. The alpha 4 beta 1 (very late antigen (VLA)-4, CD49d/CD29) and alpha 5 beta 1 (VLA-5, CD49e/CD29) integrins mediate beta 2 (CD11/CD18) integrin-independent neutrophil recruitment to endotoxin-induced lung inflammation. J Immunol. 2001;166(7):4644–4649
  107. Anderson BO, Brown JM, Shanley PF, Bensard DD, Harken AH. Marginating neutrophils are reversibly adherent to normal lung endothelium. Surgery. 1991;109(1):51–61
  108. Gao X, Xu N, Sekosan M, Mehta D, Ma SY, Rahman A, et al. Differential role of CD18 integrins in mediating lung neutrophil sequestration and increased microvascular permeability induced by Escherichia coli in mice. J Immunol. 2001;167(5):2895–2901
  109. Guo RF, Ward PA. Mediators and regulation of neutrophil accumulation in inflammatory responses in lung: insights from the IgG immune complex model. Free Radic Biol Med. 2002;33(3):303–310
  110. Kamochi M, Kamochi F, Kim YB, Sawh S, Sanders JM, Sarembock I, et al. P-selectin and ICAM-1 mediate endotoxin-induced neutrophil recruitment and injury to the lung and liver. Am J Physiol. 1999;277(2 Pt 1):L310–L319
  111. Kubo H, Doyle NA, Graham L, Bhagwan SD, Quinlan WM, Doerschuk CM. L- and P-selectin and CD11/CD18 in intracapillary neutrophil sequestration in rabbit lungs. Am J Respir Crit Care Med. 1999;159(1):267–274
  112. Lu YT, Chen PG, Liu SF. Time course of lung ischemia-reperfusion-induced ICAM-1 expression and its role in ischemia-reperfusion lung injury. J Appl Physiol. 2002;93(2):620–628
  113. Lundberg AH, Fukatsu K, Gaber L, Callicutt S, Kotb M, Wilcox H, et al. Blocking pulmonary ICAM-1 expression ameliorates lung injury in established diet-induced pancreatitis. Ann Surg. 2001;233(2):213–220
  114. Mulligan MS, Lentsch AB, Ward PA. In vivo recruitment of neutrophils: consistent requirements for L-arginine and variable requirements for complement and adhesion molecules. Inflammation. 1998;22(3):327–339
  115. Anderson BO, Brown JM, Bensard DD, Grosso MA, Banerjee A, Patt A, et al. Reversible lung neutrophil accumulation can cause lung injury by elastase-mediated mechanisms. Surgery. 1990;108(2):262–267
  116. Martin TR, Pistorese BP, Chi EY, Goodman RB, Matthay MA. Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J Clin Invest. 1989;84(5):1609–1619
  117. Silliman CC, Voelkel NF, Allard JD, Elzi DJ, Tuder RM, Johnson JL, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest. 1981;101(7):1458–1467
  118. Silliman CC, Bjornsen AJ, Wyman TH, Kelher M, Allard J, Bieber S, et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion. 2003;43(5):633–640
  119. Webster RO, Larsen GL, Mitchell BC, Goins AJ, Henson PM. Absence of inflammatory lung injury in rabbits challenged intravascularly with complement-derived chemotactic factors. Am Rev Respir Dis. 1982;125(3):335–340
  120. Doyle NA, Bhagwan SD, Meek BB, Kutkoski GJ, Steeber DA, Tedder TF, et al. Neutrophil margination, sequestration, and emigration in the lungs of L-selectin-deficient mice. J Clin Invest. 1997;99(3):526–533
  121. Horgan MJ, Ge M, Gu J, Rothlein R, Malik AB. Role of ICAM-1 in neutrophil-mediated lung vascular injury after occlusion and reperfusion. Am J Physiol. 1991;261(5 Pt 2):H1578–H1584
  122. Lo SK, Everitt J, Gu J, Malik AB. Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms. J Clin Invest. 1992;89(3):981–988
  123. Lundberg AH, Granger N, Russell J, Callicutt S, Gaber LW, Kotb M, et al. Temporal correlation of tumor necrosis factor-alpha release, upregulation of pulmonary ICAM-1 and VCAM-1, neutrophil sequestration, and lung injury in diet-induced pancreatitis. J Gastrointest Surg. 2000;4(3):248–257
  124. Downey GP, Dong Q, Kruger J, Dedhar S, Cherapanov V. Regulation of neutrophil activation in acute lung injury. Chest. 1999;116(1 Suppl):46S–54S
  125. Kopko PM, Paglieroni TG, Popovsky MA, Muto KN, MacKenzie MR, Holland PV. TRALI: correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion. 2003;43(2):177–184
  126. Behzadian MA, Windsor LJ, Ghaly N, Liou G, Tsai NT, Caldwell RB. VEGF-induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor. FASEB J. 2003;17(6):752–754
  127. Cao R, Eriksson A, Kubo H, Alitalo K, Cao Y, Thyberg J. Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res. 2004;94(5):664–670
  128. Fu BM, Shen S. Acute VEGF effect on solute permeability of mammalian microvessels in vivo. Microvasc Res. 2004;68(1):51–62
  129. Yamazaki Y, Takani K, Atoda H, Morita T. Snake venom vascular endothelial growth factors (VEGFs) exhibit potent activity through their specific recognition of KDR (VEGF receptor 2). J Biol Chem. 2003;278(52):51985–51988
  130. Muczynski KA, Cotner T, Anderson SK. Unusual expression of human lymphocyte antigen class II in normal renal microvascular endothelium. Kidney Int. 2001;59(2):488–497
  131. Riesbeck K, Billstrom A, Tordsson J, Brodin T, Kristensson K, Dohlsten M. Endothelial cells expressing an inflammatory phenotype are lysed by superantigen-targeted cytotoxic T cells. Clin Diagn Lab Immunol. 1998;5(5):675–682
  132. Waldman WJ, Knight DA, Adams PW, Orosz CG, Sedmak DD. In vitro induction of endothelial HLA class II antigen expression by cytomegalovirus-activated CD4+ T cells. Transplantation. 1993;56(6):1504–1512
  133. Gans RO, Duurkens VA, van Zundert AA, Hoorntje SJ. Transfusion-related acute lung injury. Intensive Care Med. 1988;14(6):654–657
  134. Yomtovian R, Kline W, Press C, Clay M, Engman H, Hammerschmidt D, et al. Severe pulmonary hypersensitivity associated with passive transfusion of a neutrophil-specific antibody. Lancet. 1984;1(8371):244–246
  135. Boshkov LK. Transfusion-associated acute lung injury (TRALI): an evolving understanding of the role of anti-leukocyte antibodies. Vox Sang. 2002;83(Suppl 1):299–303
  136. Popovsky MA, Chaplin HC, Moore SB. Transfusion-related acute lung injury: a neglected, serious complication of hemotherapy. Transfusion. 1992;32(6):589–592
  137. Seeger W, Schneider U, Kreusler B, von Witzleben E, Walmrath D, Grimminger F, et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood. 1990;76(7):1438–1444
  138. Bux J, Becker F, Seeger W, Kilpatrick D, Chapman J, Waters A. Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol. 1996;93(3):707–713
  139. Bux J, Hardt O, Kohstall M, Sibelius U, Weissmann N. Reproduction of granulocyte antiboy-mediated TRALI in an ex-vivo rat lung model. Blood. 2003;102(supplement):94a
  140. Sachs UJH, Hattar K, Weissmann N, Bohle RM, Weiss T, Sibelius U, Bux J. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood. In press 2005.
  141. Toy P, Hollis-Perry KM, Jun J, Nakagawa M. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury. Transfusion. 2004;44(12):1683–1688
  142. Klein JB, McLeish KR, Ward RA. Transplantation, not dialysis, corrects azotemia-dependent priming of the neutrophil oxidative burst. Am J Kidney Dis. 1999;33(3):483–491
  143. Partrick DA, Moore EE, Fullerton DA, Barnett CC, Meldrum DR, Silliman CC. Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability. J Surg Res. 1999;86(1):42–49
  144. Ward RA, McLeish KR. Hemodialysis with cellulose membranes primes the neutrophil oxidative burst. Artif Organs. 1995;19(8):801–807
  145. Curtis BR, Kelher M, McLaughlin NJD, Kopko PM, Silliman CC. The two-event model of transfusion-related acute lung injury:antibodies to HNA-3a cause PMN cytotoxicity. Blood. 2004;104(11):237a
  146. Kopko PM, Curtis BR, Kelher M, McLaughlin N, Silliman CC. Merging the pathogenesis of transfusion-related acute lung injury: the priming activity of the 5b (HNA-3) antibody. Transfusion. 2004;44(9S):22A
  147. Albrecht EA, Chinnaiyan AM, Varambally S, Kumar-Sinha C, Barrette TR, Sarma JV, et al. C5a-induced gene expression in human umbilical vein endothelial cells. Am J Pathol. 2004;164(3):849–859
  148. Varela M, Mas A, Nogues N, Escorsell A, Mazzara R, Lozano M. TRALI associated with HLA class II antibodies. Transfusion. 2002;42(8):1102
  149. Win N, Brown C, Navarrete C. TRALI associated with HLA class II antibodies. Transfusion. 2003;43(4):545–546
  150. Gosselin EJ, Wardwell K, Rigby WF, Guyre PM. Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-gamma, and IL-3. J Immunol. 1993;151(3):1482–1490
  151. Lei L, Altstaedt J, von der OM, Proft T, Gross U, Rink L. Induction of interleukin-8 in human neutrophils after MHC class II cross-linking with superantigens. J Leukoc Biol. 2001;70(1):80–86
  152. Matsumoto S, Takei M, Moriyama M, Imanishi H. Enhancement of Ia-like antigen expression by interferon-gamma in polymorphonuclear leukocytes. Chem Pharm Bull (Tokyo). 1987;35(1):436–439
  153. Reinisch W, Lichtenberger C, Steger G, Tillinger W, Scheiner O, Gangl A, et al. Donor dependent, interferon-gamma induced HLA-DR expression on human neutrophils in vivo. Clin Exp Immunol. 2003;133(3):476–484
  154. Nishimura M, Mitsunaga S, Ishikawa Y, Satake M. Possible mechanisms underlying development of transfusion-related acute lung injury: roles of anti-major histocompatibility complex class II DR antibody. Transfus Med. 2003;13(3):141–147
  155. Porretti L, Coluccio E, Prati D, Colombo MB, Lopa R, Tombolini P, et al. Flow-cytometric approach to the prompt laboratory diagnosis of TRALI: a case report. Eur J Haematol. 2004;73(4):295–299
  156. Kopko PM, Popovsky MA. Pulmonary injury from transfusion-related acute lung injury. Clin Chest Med. 2004;25(1):105–111
  157. Leavey PJ, Sellins KS, Thurman G, Elzi D, Hiester A, Silliman CC, et al. In vivo treatment with granulocyte colony-stimulating factor results in divergent effects on neutrophil functions measured in vitro. Blood. 1998;92(11):4366–4374
  158. Silliman CC, Clay KL, Thurman GW, Johnson CA, Ambruso DR. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med. 1994;124(5):684–694
  159. Silliman CC, Dickey WO, Paterson AJ, Thurman GW, Clay KL, Johnson CA, et al. Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion. 1996;36(2):133–139
  160. Silliman CC, Elzi DJ, Ambruso DR, Musters RJ, Hamiel C, Harbeck RJ, et al. Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium. J Leukoc Biol. 2003;73(4):511–524
  161. Wyman TH, Bjornsen AJ, Elzi DJ, Smith CW, England KM, Kelher M, et al. A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release. Am J Physiol Cell Physiol. 2002;283(6):C1592–C1603
  162. Ambruso DR, Giclas P, Silliman CC, Kelher M, Geier S. Complement activation associated with transfusion-related acute lung injury (TRALI). Blood. 2005;104(Supplement):743a
  163. Blumberg N, Boshkov LK, Silliman CC, Kelher M, Gettings KF, Heal JM, et al. CD40 ligand (CD154) as a cofactor in the development of transfusion-related acute lung injury (TRALI). Blood. 2004;104(11):237a–238a
  164. Adawi A, Zhang Y, Baggs R, Finkelstein J, Phipps RP. Disruption of the CD40-CD40 ligand system prevents an oxygen-induced respiratory distress syndrome. Am J Pathol. 1998;152(3):651–657
  165. Frossard JL, Kwak B, Chanson M, Morel P, Hadengue A, Mach F. Cd40 ligand-deficient mice are protected against cerulein-induced acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology. 2001;121(1):184–194
  166. Moore TM, Shirah WB, Khimenko PL, Paisley P, Lausch RN, Taylor AE. Involvement of CD40-CD40L signaling in postischemic lung injury. Am J Physiol Lung Cell Mol Physiol. 2002;283(6):L1255–L1262
  167. Phipps RP, Kaufman J, Blumberg N. Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet. 2001;357(9273):2023–2024
  168. Spiess BD, Royston D, Levy JH, Fitch J, Dietrich W, Body S, et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion. 2004;44(8):1143–1148
  169. Goodnough LT, Johnston MF, Toy PT. The variability of transfusion practice in coronary artery bypass surgery. Transfusion Medicine Academic Award Group. JAMA. 1991;265(1):86–90
  170. Goodnough LT, Soegiarso RW, Birkmeyer JD, Welch HG. Economic impact of inappropriate blood transfusions in coronary artery bypass graft surgery. Am J Med. 1993;94(5):509–514
  171. Surgenor DM, Wallace EL, Churchill WH, Hao SH, Chapman RH, Collins JJ. Red cell transfusions in coronary artery bypass surgery (DRGs 106 and 107). Transfusion. 1992;32(5):458–464
  172. Palfi M, Berg S, Ernerudh J, Berlin G. A randomized controlled trial oftransfusion-related acute lung injury: is plasma from multiparous blood donors dangerous?. Transfusion. 2001;41(3):317–322
  173. Benjamin RJ, Roggeveen B, Reeves C, Kelly ME. TRALI: components from female donors are not disproportionately involved in common transfusion reactions. Transfusion. 2004;44(9S):34A
  174. Densmore TL, Goodnough LT, Ali S, Dynis M, Chaplin H. Prevalence of HLA sensitization in female apheresis donors. Transfusion. 1999;39(1):103–106
  175. Silliman CC, Moore EE, Johnson JL, Gonzalez RJ, Biffl WL. Transfusion of the injured patient: proceed with caution. Shock. 2004;21(4):291–299
  176. Zimbelman J, Silliman CC, Ambruso DR. Transfusion-related acute lung injury and granulocytes from stored packed RBCs. Transfusion. 2000;40(5):614–615
  177. Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med. 1990;322(23):1617–1621
  178. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood. 2005;105(6):2266–2273
  179. Insunza A, Romon I, Gonzalez-Ponte ML, Hoyos A, Pastor JM, Iriondo A, et al. Implementation of a strategy to prevent TRALI in a regional blood centre. Transfus Med. 2004;14(2):157–164

PII: S0268-960X(05)00056-1

doi: 10.1016/j.blre.2005.11.001

Blood Reviews
Volume 20, Issue 3 , Pages 139-159 , May 2006

Article Tools

* Image Usage & Resolution